Is operative repair indicated for a patient with an atrial septal defect (Qp:Qs 0.71:1) and liver cirrhosis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 14, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Operative Repair is NOT Indicated for This Patient

With a Qp:Qs ratio of 0.71:1, this patient does not meet criteria for ASD closure, and the presence of liver cirrhosis significantly increases surgical risk, making operative intervention contraindicated.

Hemodynamic Assessment

The Qp:Qs ratio of 0.71:1 indicates a right-to-left shunt (or minimal left-to-right shunt), which falls well below the threshold for intervention. According to the most recent ACC/AHA guidelines 1:

  • Class I indication for ASD closure requires Qp:Qs ≥1.5:1 with right atrial/RV enlargement
  • Class III (Harm) recommendation explicitly states ASD closure should NOT be performed when there is a net right-to-left shunt 1, 2

Your patient's ratio suggests either:

  • Minimal hemodynamic significance of the ASD
  • Possible elevated pulmonary vascular resistance causing shunt reversal
  • No volume overload justifying closure

Critical Contraindications Present

Liver Cirrhosis as a Major Risk Factor

The presence of liver cirrhosis creates prohibitive surgical risk 3:

  • Child-Pugh Class B or C cirrhosis carries 50-100% mortality with open heart surgery under cardiopulmonary bypass 4
  • The 2025 EASL guidelines explicitly state that aortic and cardiac surgery should be discouraged in CTP B and C cirrhosis 3
  • Even if hemodynamic criteria were met, the cirrhosis alone would make this patient a poor surgical candidate

Shunt Direction Matters

The guidelines are unequivocal 1, 2:

  • PA systolic pressure >2/3 systemic
  • Pulmonary vascular resistance >2/3 systemic
  • Net right-to-left shunt = absolute contraindication to closure

What You Must Evaluate

Before any consideration of intervention, obtain:

  1. Comprehensive hemodynamic assessment via cardiac catheterization 1

    • Measure PA pressures directly
    • Calculate pulmonary vascular resistance
    • Confirm shunt direction and magnitude
    • Assess for pulmonary hypertension/Eisenmenger physiology
  2. Liver disease severity stratification

    • Child-Pugh classification
    • MELD score
    • Assessment of portal hypertension
  3. Right heart chamber assessment

    • Look for RV/RA enlargement on echo
    • If chambers are normal-sized with Qp:Qs <1.5:1, no intervention is needed regardless

Clinical Algorithm

If Qp:Qs <1.5:1 AND no RV enlargement → No closure indicated, medical management only

If right-to-left shunt present → Absolute contraindication to closure 1

If cirrhosis is Child-Pugh B or C → Surgery contraindicated due to prohibitive mortality risk 3, 4

If all three conditions present (as in your patient) → Medical management only, consider transplant evaluation if liver disease progresses

Common Pitfalls to Avoid

  • Do not close ASDs based on size alone - hemodynamic significance (Qp:Qs ratio and chamber enlargement) determines indication 1
  • Do not assume all ASDs need closure - small defects with Qp:Qs <1.5:1 can be observed 5
  • Do not underestimate cirrhosis as a surgical risk - mortality approaches 50-100% in advanced disease 4
  • Recognize that cardiac cirrhosis can result FROM the ASD 6 - but with this shunt ratio, the ASD is not hemodynamically significant enough to have caused the cirrhosis

Management Recommendation

Conservative medical management is the only appropriate approach:

  • Treat heart failure symptoms if present
  • Manage cirrhosis complications (ascites, encephalopathy, varices)
  • Monitor for arrhythmias (common with ASDs)
  • Serial echocardiography to assess for changes in shunt magnitude or chamber size
  • Consider hepatology/transplant evaluation given the cirrhosis

The combination of inadequate hemodynamic indication (Qp:Qs 0.71:1) and prohibitive surgical risk (cirrhosis) makes operative repair inappropriate for this patient 1, 3, 4.

Related Questions

What are the contraindications to atrial septal defect (ASD) closure?
What are the anesthetic considerations and management for an adult patient with a ventricular septal defect (VSD) or atrial septal defect (ASD) undergoing non‑cardiac surgery?
What are the indications, procedural steps, device selection, antiplatelet regimen, and follow‑up recommendations for percutaneous closure of a secundum atrial septal defect?
What is the appropriate management for a patient with an atrial septal defect (ASD) who also has a prolonged QT interval?
In a 57‑year‑old diabetic female with a newly diagnosed ostium secundum atrial septal defect causing a left‑to‑right shunt and dilated right atrium and right ventricle, what clinical findings should be expected?
In a term woman not in labor with ruptured membranes and moderate watery vaginal discharge, how long can we wait before definitive delivery management?
In a colon cancer patient receiving CAPOX (capecitabine and oxaliplatin) with persistent neutropenia causing a chemotherapy delay, can pegfilgrastim (Neulasta) be given 48 hours after the oxaliplatin infusion?
Which electrolyte abnormalities can cause hypomagnesemia?
In a healthy 17‑ to 20‑year‑old female, are vesicular lesions considered normal?
For a patient whose chemotherapy cycle has been delayed five weeks due to persistent neutropenia, is it appropriate to give filgrastim (granulocyte‑colony stimulating factor) three days before chemotherapy and then administer pegfilgrastim (pegylated filgrastim) three days after the oxaliplatin infusion?
How should doxylamine be used and dosed for persistent vomiting in an adult without contraindications?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.